Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,305.00    -15.00 (-0.65%)
Bid:
2,300.00
Ask:
2,305.00
Spread: 5.00 (0.217%)
Market Cap: £3.13b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

20 Feb 2025 07:00

RNS Number : 7524X
RIT Capital Partners PLC
20 February 2025
 

RIT Capital Partners PLC (LEI: P31Q1NLTW35JJGHA4667)

20 February 2025

January 2025 Net Asset Value

RIT's unaudited diluted NAV at 31 January 2025 (with debt at fair value) was 2,682p per £1 ordinary share (31 December 2024: 2,614p1), +2.6% from the previous month. Over the same period, the Company's two indices, CPI plus 3% and the MSCI All Country World Index (50% sterling) were up +0.5% and +3.6% respectively.

Performance Highlights

Global equity markets rebounded in January, recovering from December losses amid a favourable macroeconomic backdrop of moderating inflation and solid GDP growth. The US market underperformed the rest of the world by the greatest extent in 25 months, as the market weighed the impact of the policies of the new Trump administration.

European equities extended their December gains, supported by positive economic data showing a resilient labour market and improving forward-looking indicators. Commodities also rose, led by gains in precious metals.

Against this backdrop, our portfolio performed well during the month, driven primarily by Quoted Equities, with positive returns from both Private Investments and Uncorrelated Strategies.

Specific highlights for the month include:

·

The value of our Quoted Equities book increased meaningfully. Contributors in directly held stocks included Quality companies and SMID-cap stocks, while our specialist managers performed well in China and Healthcare themes.

·

Private Investments also rose in value after we received the initial fourth quarter valuations from our fund investments. We also saw gains from the sale of a direct private investment, Xapo Bank, the first regulated cryptocurrency bank globally, at a sizeable uplift to its most recent valuation. As of 31 January, 10% of our private funds were held at 31 December reported valuations, with the remainder held at 30 September reported valuations.

·

Uncorrelated Strategies contributed to our NAV, with gains from absolute return strategies and gold, which reached an all-time high in January. These gains were offset by modest detraction from our exposure to Carbon Credits.

·

Currencies benefited our NAV during the month, primarily due to the US dollar's appreciation against sterling, which led to positive translation impacts for our portfolio.

·

We continued our ongoing share buyback programme, repurchasing £1.6 million or approximately 80,000 shares in January.

1 As is customary at this point in our year-end process, the preliminary December NAV and associated performance numbers for 2024 are estimates, and subject to potential adjustment and audit. Changes made to the December 2024 NAV could impact January's opening NAV and therefore January's performance. The 2024 Annual Report and Accounts are expected to be finalised and published by early March.

 

 

 

For more information:

J. Rothschild Capital Management (Manager):

T: 020 7647 8565

E: investorrelations@ritcap.co.uk

 

Deutsche Numis (Joint broker):

David Benda

T: 020 7260 1000

 

JP Morgan Cazenove (Joint broker):

William Simmonds

T: 020 3493 8000

 

Brunswick Group LLP (Media enquiries):

Nick Cosgrove, Sofie Brewis

T: 020 7404 5959

E: RIT@BrunswickGroup.com 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVQKLFFELLZBBF
Date   Source Headline
23rd Dec 20207:00 amRNSDirector/PDMR Shareholding
16th Dec 20207:00 amRNSTransaction in Own Shares
15th Dec 20207:00 amRNSTransaction in Own Shares
14th Dec 20207:00 amRNSNet Asset Value(s)
4th Dec 20205:36 pmRNSDirector/PDMR Shareholding
20th Nov 20204:04 pmRNSDirector/PDMR Shareholding
17th Nov 20205:27 pmRNSDirector/PDMR Shareholding
13th Nov 20207:00 amRNSNet Asset Value(s)
2nd Nov 20207:30 amRNSTransaction in Own Shares
30th Oct 20207:30 amRNSTransaction in Own Shares
15th Oct 20207:00 amRNSNet Asset Value(s)
15th Sep 20207:00 amRNSNet Asset Value(s)
17th Aug 20207:00 amRNSNet Asset Value(s)
4th Aug 20207:00 amRNSHalf-year Report
21st Jul 20207:00 amRNSNet Asset Value(s)
10th Jul 20205:25 pmRNSCommittee changes
18th Jun 20203:45 pmRNSDirector/PDMR Shareholding
15th Jun 20207:00 amRNSNet Asset Value(s)
26th May 20205:15 pmRNSResult of AGM
18th May 20207:00 amRNSNet Asset Value(s)
7th May 20206:02 pmRNSDirector/PDMR Shareholding
30th Apr 202011:12 amRNSDisclosure of Rights Attached To Ordinary Shares
21st Apr 202010:05 amRNSNotice of AGM
17th Apr 20207:00 amRNSNet Asset Value(s)
6th Apr 20205:41 pmRNSDirector/PDMR Shareholding
1st Apr 20204:06 pmRNSDirector/PDMR Shareholding
24th Mar 20205:16 pmRNSAnnual General Meeting 2020 postponement
16th Mar 20207:00 amRNSNet Asset Value(s)
11th Mar 20203:47 pmRNSDirector/PDMR Shareholding
3rd Mar 20207:00 amRNSAnnual Financial Report
17th Feb 20207:00 amRNSNet Asset Value(s)
5th Feb 20207:00 amRNSNet Asset Value(s)
7th Jan 20204:19 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
17th Dec 20197:00 amRNSIssue of Equity
16th Dec 20197:00 amRNSNet Asset Value(s)
4th Dec 20195:02 pmRNSComposition of Board Committee
15th Nov 20197:00 amRNSNet Asset Value(s)
22nd Oct 20195:10 pmRNSHolding(s) in Company
14th Oct 20197:00 amRNSNet Asset Value(s)
3rd Oct 20193:17 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
17th Sep 201912:18 pmRNSCorrection
16th Sep 20197:00 amRNSNet Asset Value(s)
14th Aug 20197:00 amRNSNet Asset Value(s)
5th Aug 20197:00 amRNSHalf-year Report
17th Jul 20197:00 amRNSNet Asset Value(s)
3rd Jul 20192:42 pmRNSQuarterly Disclosure: Listing Rule 15.6.8
18th Jun 20195:04 pmRNSDirector/PDMR Shareholding
17th Jun 20194:20 pmRNSHolding(s) in Company
14th Jun 20197:00 amRNSNet Asset Value(s)
15th May 20197:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.